Learn More
Nimotuzumab is a humanized IgG1 monoclonal antibody against the EGFR extracellular domain that has been evaluated in solid tumors as a single agent or in combination with chemotherapy and radiation.(More)
e11538 Background: Monoclonal antibodies, such as bevacizumab, stop tumor growth and block the ability of tumor cells to grow and spread. Others drugs find tumor cells and help kill them or carry(More)